Image for illustrative purposes only. Not a real photo.

Disc Medicine unveils positive multi-program clinical trial data at EHA 2026

Written by Isaac FrancisPublished Jun 12, 2026, 1:12 PM

Disc Medicine (NASDAQ:IRON) disclosed positive, updated clinical data across its core hematology pipeline during the 2026 European Hematology Association (EHA) Annual Meeting in Stockholm, Sweden.

More ways to discover

Browse United States news Discover NYSE signals Browse all NYSE stocks Browse all NYSE ETFs Explore United States companies Find the right NYSE index

More ways to discover

Assets related to this article